The De La Salle Medical and Health Sciences Institute is a medical school and allied health institution in Dasmariñas, Cavite, Philippines. It was established in 1979 and is a constituent of De La Salle Philippines.

During the past decade, De La Salle Health Sciences Institute conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 7 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "De La Salle Health Sciences Institute" #1 sponsor was "EuBiologics Co.,Ltd" with 2 trials, followed by "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Takeda" with 2 trials sponsored and "Anika Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "De La Salle Health Sciences Institute" #1 collaborator was "National University Hospital, Singapore" with 1 trials as a collaborator, "Novotech (Australia) Pty Limited" with 1 trials as a collaborator, "Singapore Clinical Research Institute (SCRI)" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "West China Hospital" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "De La Salle Health Sciences Institute" are "Arthritis, Rheumatoid" (2 trials), "Multidrug Resistant Tuberculosis" (2 trials), "Typhoid Fever" (2 trials), "Anaemia Associated With Chronic Kidney Disease" (1 trials) and "COVID-19" (1 trials). Many other conditions were trialed in "De La Salle Health Sciences Institute" in a lesser frequency.

Most popular intervention types in "De La Salle Health Sciences Institute" are "Drug" (9 trials), "Biological" (8 trials), "Device" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ethambutol" (2 trials), "Isoniazid" (2 trials), "Pyrazinamide" (2 trials), "Rifampicin" (2 trials) and "10 mg Delamanid Pediatric Formulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "De La Salle Health Sciences Institute" are 17 trials for "All" genders.

Currently, there are NaN active trials in "De La Salle Health Sciences Institute". undefined are not yet recruiting, 1 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in De La Salle Health Sciences Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in De La Salle Health Sciences Institute, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".